Variation in Human Papillomavirus Vaccination Effectiveness in the US by Age at Vaccination

Didem Egemen; Hormuzd A Katki; Anil K Chaturvedi; Rebecca Landy; Li C Cheung

doi:10.1001/jamanetworkopen.2022.38041

Variation in Human Papillomavirus Vaccination Effectiveness in the US by Age at Vaccination

JAMA Netw Open. 2022 Oct 3;5(10):e2238041. doi: 10.1001/jamanetworkopen.2022.38041.

Authors

Didem Egemen¹, Hormuzd A Katki¹, Anil K Chaturvedi¹, Rebecca Landy¹, Li C Cheung¹

Affiliation

¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland.

No abstract available

Plain language summary

This survey study assesses the status and timing of HPV vaccination as self-reported by female participants in the National Health and Nutrition Examination Survey from 2011 to 2018.

Publication types

Research Support, N.I.H., Intramural

MeSH terms

Alphapapillomavirus*
Humans
Immunization
Papillomavirus Infections* / epidemiology
Papillomavirus Infections* / prevention & control
Papillomavirus Vaccines* / therapeutic use
Vaccination

Substances

Papillomavirus Vaccines